Theravance Biopharma Inc (TBPH) — Free Cash Flow Generation Index
Theravance Biopharma Inc (TBPH) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $208.04 Million represents 1% of operating cash flow ($208.07 Million). Read Theravance Biopharma Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Theravance Biopharma Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Theravance Biopharma Inc across 1 annual periods. Explore TBPH capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Theravance Biopharma Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Theravance Biopharma Inc. For the full company profile including market capitalisation, see Theravance Biopharma Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $238.50 Million | $238.54 Million | $42.00K | — |